The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102
Abstract
Purpose: Uncontrolled studies suggest that chemoradiation has similar efficacy as surgery for esophageal cancer. Therefore, a randomized trial was carried out to compare, in responders only, chemoradiation alone with chemoradiation followed by surgery in patients with locally advanced tumors. Patients and Methods: Eligible patients had operable T3N0-1M0 thoracic esophageal cancer. Patients received two cycles of fluorouracil (FU) and cisplatin (days 1 to 5 and 22 to 26) and either conventional (46 Gy in 4.5 weeks) or split-course (15 Gy, days 1 to 5 and 22 to 26) concomitant radiotherapy. Patients with response and no contraindication to either treatment were randomly assigned to surgery (arm A) or continuation of chemoradiation (arm B; three cycles of FU/cisplatin and either conventional [20 Gy] or split-course [15 Gy] radiotherapy). Chemoradiation was considered equivalent to surgery if the difference in 2-year survival rate was less than 10%. Results: Of 444 eligible patients, 259 were randomly assigned; 230 patients (88.8%) had epidermoid cancer, and 29 (11.2%) had glandular carcinoma. Two-year survival rate was 34% in arm A versus 40% in arm B (hazard ratio for arm B v arm A = 0.90; adjusted P = .44). Median survival time was 17.7 months in arm A compared with 19.3 months in arm B. Two-year local control rate was 66.4% in arm A compared with 57.0% in arm B, and stents were less required in the surgery arm (5% in arm A v 32% in arm B; P < .001). The 3-month mortality rate was 9.3% in arm A compared with 0.8% in arm B (P = .002). Cumulative hospital stay was 68 days in arm A compared with 52 days in arm B (P = .02). Conclusion: Our data suggest that, in patients with locally advanced thoracic esophageal cancers, especially epidermoid, who respond to chemoradiation, there is no benefit for the addition of surgery after chemoradiation compared with the continuation of additional chemoradiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
Walsh, T. N., Noonan, N., Hollywood, D., Kelly, A., Keeling, N., & Hennessy, T. P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350702 · Cited by 1,950
Hulscher, J. B. F., van Sandick, J. W., de Boer, A. G. E. M., Wijnhoven, B. P. L., Tijssen, J. G. P., Fockens, P., Stalmeier, P. F. M., ten Kate, F. J. W., van Dekken, H., Obertop, H., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa022343 · Cited by 1,629
Minsky, B. D., Pajak, T. F., Ginsberg, R. J., Pisansky, T. M., Martenson, J. A., Komaki, R. U., Okawara, G. S., Rosenthal, S. A., & Kelsen, D. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1167 · Cited by 1,615
Measuring the quality of life of cancer patients
Spitzer, W. O., Dobson, A. J., Hall, J., Chesterman, E., Levi, J., Shepherd, R., Battista, R. N., & Catchlove, B. R. (1981) · Journal of Chronic Diseases · doi:10.1016/0021-9681(81)90058-8 · Cited by 1,528
(2002) · The Lancet · doi:10.1016/s0140-6736(02)08651-8 · Cited by 1,459
Bosset, J.-F., Gignoux, M., Triboulet, J.-P., Tiret, E., Mantion, G., Elias, D., Lozach, P., Ollier, J.-C., Pavy, J.-J., Mercier, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370304 · Cited by 1,376
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer, J., Estes, N., Haller, D. G., Ajani, J., Kocha, W., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812313392704 · Cited by 1,343
Stahl, M., Stuschke, M., Lehmann, N., Meyer, H.-J., Walz, M. K., Seeber, S., Klump, B., Budach, W., Teichmann, R., Schmitt, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.034 · Cited by 1,314
Urba, S. G., Orringer, M. B., Turrisi, A., Iannettoni, M., Forastiere, A., & Strawderman, M. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.305 · Cited by 1,266
al-Sarraf, M., Martz, K., Herskovic, A., Leichman, L., Brindle, J. S., Vaitkevicius, V. K., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.277 · Cited by 739
Urschel, J. D., & Vasan, H. (2003) · The American Journal of Surgery · doi:10.1016/s0002-9610(03)00066-7 · Cited by 737
Prise, E. L., Etienne, P. L., Meunier, B., Maddern, G., Hassel, M. B., Gedouin, D., Boutin, D., Campion, J. P., & Launois, B. (1994) · Cancer · doi:10.1002/1097-0142(19940401)73:7<1779::aid-cncr2820730702>3.0.co;2-t · Cited by 617
Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis
Fiorica, F., Di Bona, D., Schepis, F., Licata, A., Shahied, L., Venturi, A., Falchi, A. M., Craxì, A., & Cammà, C. (2004) · Gut · doi:10.1136/gut.2003.025080 · Cited by 539
Wieder, H. A., Brücher, B. L. D. M., Zimmermann, F., Becker, K., Lordick, F., Beer, A., Schwaiger, M., Fink, U., Siewert, J. R., Stein, H. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.122 · Cited by 454
Coia, L. R., Engstrom, P. F., Paul, A. R., Stafford, P. M., & Hanks, G. E. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90134-p · Cited by 266
Treatment Outcomes of Resected Esophageal Cancer
Hofstetter, W., Swisher, S. G., Correa, A. M., Hess, K., Putnam, J. B., Ajani, J. A., Dolormente, M., Francisco, R., Komaki, R. R., Lara, A., et al. (2002) · Annals of Surgery · doi:10.1097/00000658-200209000-00014 · Cited by 259
The role of surgery in the management of oesophageal cancer
Wu, P. C., & Posner, M. C. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01167-7 · Cited by 256
Kaklamanos, I. G., Walker, G. R., Ferry, K., Franceschi, D., & Livingstone, A. S. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.078 · Cited by 236
Urschel, J. D., Vasan, H., & Blewett, C. J. (2002) · The American Journal of Surgery · doi:10.1016/s0002-9610(02)00795-x · Cited by 192
Cited by
Tumor heterogeneity: Causes and consequences
Marusyk, A., & Polyak, K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.11.002 · Cited by 1,602
Lagergren, J., Smyth, E., Cunningham, D., & Lagergren, P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31462-9 · Cited by 1,141
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Lordick, F., Mariette, C., Haustermans, K., Obermannová, R., & Arnold, D. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw329 · Cited by 1,098
Self-citationAjani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Corvera, C., Das, P., Denlinger, C. S., Enzinger, P. C., Fanta, P., Farjah, F., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0033 · Cited by 1,059
Smyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,012
Metadata
- Authors
- Bedenne, L., Michel, P., Bouché, O., Milan, C., Mariette, C., Conroy, T., Pezet, D., Roullet, B., Seitz, J.-F., Herr, J.-P., Paillot, B., Arveux, P., Bonnetain, F., & Binquet, C.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-04-01
- Volume
- 25
- Issue
- 10
- Pages
- 1160-1168
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2122166737
- Cited by
- 1,244
- References
- 20
- FWCI
- 56.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.